A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

Journal of Neuroscience

Volumn 19, Issue 21, 1999, Pages 9192-9200

  Chen, Jiang Fan ^a,b   Huang, Zhihong ^a   Ma, Jianya ^a   Zhu, JinMin ^a   Moratalla, Rosario ^a   Standaert, David ^a   Moskowitz, Michael A ^a   Fink, J Stephen ^a   Schwarzschild, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MA GenHosp   (United States)

Author keywords

A(2A) adenosine receptor; Ischemia; Knock out; Neuroprotection; Purine receptor; Stroke

Indexed keywords

ADENOSINE A2A RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; MIDDLE CEREBRAL ARTERY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE FIBER; STROKE; THROMBOCYTE AGGREGATION;

EID: 0033232779     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.19-21-09192.1999     Document Type: Article

References (53)

1. Banbury conference on genetic background in mice (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 19:755-759.
2. Bona E, Aden U, Gilland E, Fredholm BB, Hagberg H (1997) Neonatal cerebral hypoxia ischemia: the effect of adenosine receptor antagonists. Neuropharmacology 36:1327-1338.
3. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA, Sapirstein A (1997) Reduced fertility and postischemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390:622-625,
4. Chen J-F, Fink JS (1996) Characterization of the genomic structure of mouse A2aR adenosine receptor gene. Soc Neurosci Abstr 22:1569.
5. Coney AM, Marshall JM (1988) Role of adenosine and its receptors in the vasodilation induced in the cerebral cortex of the rat by systemic hypoxia. J Physiol (Lond) 509:507-518.
6. Corsi C, Pazzagli M, Bianchi L, Della Corte L, Pepeu G, Pedata F (1997) In vivo amino acid release from the striatum of aging rats: adenosine modulation. Neurobiol Aging 18:243-250.
7. Cronstein BN (1994) Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13.
8. Deckert J, Gleiter CH (1994) Adenosine-an endogenous neuroprotective metabolite and neuromodulator. J Neural Transm 43:23-31.
9. Dunwiddie TV, Fredholm BB (1997) Adenosine neuromodulation. In: Purinergic approaches in experimental therapeutics (Jacobson KA, Jarvis MF, eds), pp 359-382. New York: Wiley-Liss.
10. Fink JS, Weaver DR, Rivkees SA, Peterfreund RA, Pollack AE, Adler EM, Reppert SM (1992) Molecular cloning of the rat A2 adenosine receptor: selective cocxpression with D2 dopamine receptors in rat striatum. Mol Brain Res 14:186-195.
11. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
12. Fredholm BB, Arslan G, Kull B, Kontny E, Svenningsson P (1997) Adenosine (P1) receptor signalling. Drug Dev Res 39:262-268.
13. Gao Y, Phillis JW (1994) CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischaemic injury in the Mongolian gerbil. Life Sci 55:PL61-PL65.
14. Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254.
15. 2A receptor involves activation of both N- and P-type calcium channels by different G proteins and protein kinases in the same striatal nerve terminals. J Neurochem 67:374-381.
16. Hagberg H, Andersson P, Lacarewicz J, Jacobson I, Butcher S, Sandberg M (1987) Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem 49:227-231.
17. Hara H, Huang PL, Panahian N, Fishman MC, Moskowitz MA (1996) Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab 16:605-611.
18. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883-1885.
19. Ibayashi S, Ngai AC, Meno JR, Winn HR (1991) Effects of topical adenosine analogs and forskolin on rat pial arterioles in vivo. J Cereb Blood Flow Metab 11:72-76.
20. Jacobson KA, van Galen, PJ, Williams M (1992) Adenosine receptors -pharmacology, structure activity relationships, and therapeutic potential. J Med Chem 35:407-422.
21. Jacobson KA, von Lubitz DK, Daly JW, Fredholm BB (1996) Adenosine receptor ligands: differences with acute versus chronic treatment. Trend Pharmacol Sci 17:108-113.
22. 3H]CGS 21680 to rat cortex differs from its binding to rat striatum. Eur J Pharmacol 247:103-110.
23. 2A receptor agonists and antagonists. Neuroscience 85:229-237.
24. 2receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence. J Pharmacol Exp Ther 280:301-309.
25. Kalaria RN, Harik SI (1986) Adenosine receptors of cerebral microvessels and choroid plexus. J Cereb Blood Flow Metab 6:463-470.
26. 2A receptor. Nature 388:674-678.
27. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
28. Matsumoto K, Graf R, Rosner G, Shimada N, Heiss W-D (1992) Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia. Brain Res 579:309-314.
29. 2A adenosine receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats. NeuroReport 9:3955-3959.
30. Moratalla R, Elibol B, Vallejo M, Graybiel AM (1996) Network-level changes in inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17:147-156.
31. 2A receptors. Trend Pharmacol Sci 17:364-372.
32. Ongini E, Dionisotti S, Gessi S, Irenius E, Fredholm BB (1999) Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 359:7-10.
33. 2 agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci Lett 138:169-172.
34. Peterfreund RA, MacCollin M, Gusella J, Fink JS (1996) Characterization and expression of the human A2aR adenosine receptor gene. J Neurochem 66:362-368.
35. Phillis JW (1989) Adenosine in the control of the cerebral circulation. Cerebrovasc Brain Metab Rev 1:26-54.
36. 1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res 705:79-84.
37. Phillis JW (1997) Adenosine agonists and antagonists. In: Primer on cerebrovascular disease (Welch KMA, Caplan LR, Reis DJ, Siesjo BK, Weir B, eds), pp 250-253. San Diego: Academic.
38. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 287:215-217.
39. Pulsinelli W, Sarokin A, Buchan A (1993) Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia. Prog Brain Res 96:125-135.
40. 2A receptors in the rat central nervous system. J Comp Neurol 401:163-186.
41. Rudolphi K, Schubert P, Parkinson FE Fredholm BB (1992) Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci 13:439-445.
42. 1 and A2 receptor agonists on platelet aggregation in the rabbit. Eur J Pharmacol 259:43-49.
43. Schauwecker PE, Steward O (1997) Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches. Proc Natl Acad Sci USA 94:4103-4108.
44. 2A receptor agonist CGS 21680. Drug Dev Res 39:108-114.
45. Schiffmann SN, Jacobs O, Vanderhaeghen J-J (1991) Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem 57:1062-1067.
46. Sebastiao AM, Ribeiro JA (1996) Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog Neurobiol 48:167-189.
47. Silva AJ, Smith AM, Gieses KP (1997) Gene targeting and the biology of learning and memory. Annu Rev Genet 31:527-546.
48. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ (1997) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19-27.
49. Simpson RE, O'Regan MH, Perkins LM, Phillis JW (1992) Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists. J Neurochem 58:1683-1690.
50. 2A receptor mRNA in the primate striatum. J Comp Neurol 399:229-240.
51. von Lubitz DJKE (1997) Adenosine and acute treatment of cerebral ischemia and stroke - "put out more flags." In: Purinergic approaches in experimental therapeutics (Jacobson KA, Jarvis MF, eds), pp 449-470. New York. Wiley-Liss.
52. 2A receptor agonist and antagonist. Eur J Pharmacol 287:295-302.
53. 2A adenosine receptor gene expression in developing rat brain. Brain Res Mol Brain Res 20:313-327.